Global Report - Pharmaceutical Executive


Global Report
News, markets, and regulation in Europe, Asia, and South America.

Whatever Happened To Faster Reimbursement For Generics In Europe?

April 1, 2014

The plan to accelerate generic pricing and reimbursement has become another tragic European casualty.

The Italian's Job

March 1, 2012

After his predecessor and countryman left the EMA in disgrace, Guido Rasi jumps in as executive director—with great challenges ahead.

Industry/Gov't R&D Support: So Far So Good

February 1, 2012

The EU's Innovative Medicines Initiative is helping to invigorate new drug development, but there are still many hurdles to tackle before its promise is realized.

Here's to a Happier New Year?

January 1, 2012

A turbulent year is ahead for European pharma, while EFPIA's Director General begins to rethink its approach to new science.

Europe's Transparency Directive Revisited

December 1, 2011

The effect on pharma of the EU's Transparency Directive has been overly constraining, but will the mooted revisions offer any room to maneuver?

Does a German Launch Make Sense?

November 1, 2011

Will the structure and ambiguity of Germany's new medicines pricing system bring a halt to new drug launches in Europe's largest market?

Europe Tackles 'Advertising in Disguise' Fears

November 1, 2011

The EC's latest proposals have thrown water on Europe's firey Direct-to-Consumer advertising debate. But is it enough to keep the flames at bay?

Emerging Markets:The Myths and Traps

October 1, 2011

Success in the emerging markets depends significantly on navigating the myths and mental traps.

Sweden: Setting the Pace for Global Pharma

October 1, 2011

Garbo gets it ...


Click here